Oral azacitidine preserves favorable level of fatigue and health-related quality of life for patients with acute myeloid leukemia in remission: results from the phase III, placebo-controlled QUAZAR AML-001 trial

• Authors: ROBOZ GJ; DOHNER H; POCOCK C; DOMBRET H; RAVANDI F; JANG JH; SELLESLAG D; MAYER Jiří; MARTENS UM; LIESVELD J; BERNAL T; WANG MC; YU PW; SHI L; GUO S; LA Torre I; SKIKNE B; DONG Q; BRAVERMAN J; NEHME SA; BEACH CL; WEI AH
• Year of publication: 2021
• Type: Article in Periodical
• Magazine / Source: haematologica
• MU Faculty or unit: Faculty of Medicine
• Doi: http://dx.doi.org/10.3324/haematol.2021.279174